Interaction between metabolic syndrome and alcohol consumption, risk factors of liver fibrosis: A population‐based study
Published 2021 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Interaction between metabolic syndrome and alcohol consumption, risk factors of liver fibrosis: A population‐based study
Authors
Keywords
-
Journal
LIVER INTERNATIONAL
Volume -, Issue -, Pages -
Publisher
Wiley
Online
2021-02-18
DOI
10.1111/liv.14830
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- The global, regional, and national burden of cirrhosis by cause in 195 countries and territories, 1990–2017: a systematic analysis for the Global Burden of Disease Study 2017
- (2020) Sadaf G Sepanlou et al. Lancet Gastroenterology & Hepatology
- Non-Invasive Assessment of Liver Disease in Patients with NAFLD
- (2019) Laurent Castera et al. GASTROENTEROLOGY
- Fibrosis and alcohol-related liver disease
- (2019) Carolin Lackner et al. JOURNAL OF HEPATOLOGY
- Low levels of alcohol consumption, obesity and development of fatty liver with and without evidence of advanced fibrosis
- (2019) Yoosoo Chang et al. HEPATOLOGY
- Risks of light and moderate alcohol use in fatty liver disease – follow‐up of population cohorts
- (2019) Fredrik Åberg et al. HEPATOLOGY
- Transient elastography for screening of liver fibrosis: cost-effectiveness analysis from six prospective cohorts in Europe and Asia
- (2019) Miquel Serra-Burriel et al. JOURNAL OF HEPATOLOGY
- High Prevalence of Liver Fibrosis Among European Adults With Unknown Liver Disease: A Population-Based Study
- (2018) Llorenç Caballería et al. Clinical Gastroenterology and Hepatology
- Among Patients With Nonalcoholic Fatty Liver Disease, Modest Alcohol Use Is Associated With Less Improvement in Histologic Steatosis and Steatohepatitis
- (2018) Veeral Ajmera et al. Clinical Gastroenterology and Hepatology
- The bidirectional impacts of alcohol consumption and the metabolic syndrome: Cofactors for progressive fatty liver disease
- (2018) Marie Boyle et al. JOURNAL OF HEPATOLOGY
- Modeling NAFLD disease burden in China, France, Germany, Italy, Japan, Spain, United Kingdom, and United States for the period 2016–2030
- (2018) Chris Estes et al. JOURNAL OF HEPATOLOGY
- Burden of liver disease in Europe: Epidemiology and analysis of risk factors to identify prevention policies
- (2018) Laura Pimpin et al. JOURNAL OF HEPATOLOGY
- Disease burden and costs from excess alcohol consumption, obesity, and viral hepatitis: fourth report of the Lancet Standing Commission on Liver Disease in the UK
- (2018) Roger Williams et al. LANCET
- Effect of alcohol consumption on survival in non-alcoholic fatty liver disease: a national prospective cohort study
- (2018) Kaveh Hajifathalian et al. HEPATOLOGY
- Prevalence of hepatic steatosis as assessed by controlled attenuation parameter (CAP) in subjects with metabolic risk factors in primary care. A population-based study
- (2018) Núria Fabrellas et al. PLoS One
- Is moderate alcohol use in nonalcoholic fatty liver disease good or bad? A critical review
- (2017) Veeral H. Ajmera et al. HEPATOLOGY
- Impact of anthropometric features on the applicability and accuracy of FibroScan® (M and XL) in overweight/obese patients
- (2017) Marc Puigvehí et al. JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY
- Global burden of NAFLD and NASH: trends, predictions, risk factors and prevention
- (2017) Zobair Younossi et al. Nature Reviews Gastroenterology & Hepatology
- Governmental standard drink definitions and low-risk alcohol consumption guidelines in 37 countries
- (2016) Agnieszka Kalinowski et al. ADDICTION
- Liver stiffness measurement using acoustic radiation force impulse elastography in overweight and obese patients
- (2016) D. Attia et al. ALIMENTARY PHARMACOLOGY & THERAPEUTICS
- Contribution of Alcoholic and Nonalcoholic Fatty Liver Disease to the Burden of Liver-Related Morbidity and Mortality
- (2016) Zobair Younossi et al. GASTROENTEROLOGY
- Critical comparison of elastography methods to assess chronic liver disease
- (2016) Mireen Friedrich-Rust et al. Nature Reviews Gastroenterology & Hepatology
- Altered Bile Acid Metabolome in Patients with Nonalcoholic Steatohepatitis
- (2015) Brian C. Ferslew et al. DIGESTIVE DISEASES AND SCIENCES
- EASL-ALEH Clinical Practice Guidelines: Non-invasive tests for evaluation of liver disease severity and prognosis
- (2015) JOURNAL OF HEPATOLOGY
- Colonic inflammation and secondary bile acids in alcoholic cirrhosis
- (2014) Genta Kakiyama et al. AMERICAN JOURNAL OF PHYSIOLOGY-GASTROINTESTINAL AND LIVER PHYSIOLOGY
- Characterization of gut microbiomes in nonalcoholic steatohepatitis (NASH) patients: A connection between endogenous alcohol and NASH
- (2012) Lixin Zhu et al. HEPATOLOGY
- Modest alcohol consumption is associated with decreased prevalence of steatohepatitis in patients with non-alcoholic fatty liver disease (NAFLD)
- (2012) Winston Dunn et al. JOURNAL OF HEPATOLOGY
- Feasibility and diagnostic performance of the FibroScan XL probe for liver stiffness measurement in overweight and obese patients
- (2011) Robert P. Myers et al. HEPATOLOGY
- Components of metabolic syndrome are independent predictors of mortality in patients with chronic liver disease: a population-based study
- (2010) M. Stepanova et al. GUT
- Comparison of Noninvasive Markers of Fibrosis in Patients With Nonalcoholic Fatty Liver Disease
- (2009) Amy G. Shah et al. Clinical Gastroenterology and Hepatology
- Natural Course of Chronic HCV and HBV Infection and Role of Alcohol in the General Population: The Dionysos Study
- (2008) Giorgio Bedogni et al. AMERICAN JOURNAL OF GASTROENTEROLOGY
- Mechanisms of Disease Progression in Nonalcoholic Fatty Liver Disease
- (2008) Janice Jou et al. SEMINARS IN LIVER DISEASE
Add your recorded webinar
Do you already have a recorded webinar? Grow your audience and get more views by easily listing your recording on Peeref.
Upload NowAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started